Table 1.
Lifetime burden of tuberculosis stratified by RS-TB and RR-TB, globally and per incident tuberculosis case, 2020
| Form of disease | Outcome | TB disease | Post-TB | Total |
|---|---|---|---|---|
| Total global DALYs (millions) | ||||
| RS-TB | YLLs | 63.5 (55.5, 72.1) | 39.7 (25.6, 57.9) | 103.2 (86.4, 122.2) |
| YLDs | 4.9 (2.5, 8.3) | 14.5 (8.3, 23.5) | 19.4 (12.4, 28.5) | |
| DALYs | 68.4 (59.7, 77.6) | 54.2 (35.6, 79.7) | 122.6 (100.8, 149.0) | |
| RR-TB | YLLs | 3.6 (3.1, 4.3) | 2.2 (1.3, 3.2) | 5.9 (4.8, 7.1) |
| YLDs | 0.2 (0.1, 0.3) | 0.9 (0.4, 1.4) | 1.1 (0.6, 1.6) | |
| DALYs | 3.8 (3.2, 4.4) | 3.1 (1.8, 4.4) | 6.9 (5.5, 8.5) | |
| All disease | YLLs | 67.1 (58.8, 76.1) | 42.0 (27.6, 60.7) | 109.1 (91.9, 128.9) |
| YLDs | 5.1 (2.6, 8.6) | 15.3 (8.8, 24.7) | 20.4 (13.1, 29.9) | |
| DALYs | 72.2 (63.2, 81.9) | 57.3 (37.7, 83.5) | 129.5 (107.1, 156.9) | |
| DALYs per incident tuberculosis case | ||||
| RS-TB | YLLs | 6.7 (5.9, 7.5) | 4.2 (2.8, 6.0) | 10.9 (9.3, 12.7) |
| YLDs | 0.5 (0.3, 0.9) | 1.5 (0.9, 2.5) | 2.0 (1.3, 3.0) | |
| DALYs | 7.2 (6.4, 8.0) | 5.7 (3.7, 8.4) | 12.9 (10.8, 15.6) | |
| RR-TB | YLLs | 9.1 (7.6, 10.5) | 5.6 (3.3, 7.8) | 14.6 (12.0, 17.1) |
| YLDs | 0.5 (0.2, 0.8) | 2.1 (1.1, 3.3) | 2.6 (1.6, 3.9) | |
| DALYs | 9.6 (8.1, 11.0) | 7.7 (4.5, 10.7) | 17.3 (13.8, 20.6) | |
| All disease | YLLs | 6.8 (6.0, 7.6) | 4.2 (2.8, 6.1) | 11.0 (9.4, 12.8) |
| YLDs | 0.5 (0.3, 0.9) | 1.5 (0.9, 2.5) | 2.1 (1.3, 3.0) | |
| DALYs | 7.3 (6.5, 8.1) | 5.8 (3.8, 8.4) | 13.1 (11.0, 15.7) | |
YLLs ‘years of life lost’ due to fatal disease consequences, YLDs ‘years lived with disability’ due to non-fatal disease consequences, DALYs disability-adjusted life years (the sum of YLLs and YLDs), RR-TB rifampicin-resistant tuberculosis, RS-TB rifampicin-susceptible tuberculosis.
Values in parentheses represent 95% uncertainty intervals.